{
  "case_id": "tmpqxoi3p9n",
  "model_id": "shisa-ai/shisa-v2-llama3.3-70b:free",
  "content": "```json\n{\n  \"primary_diagnosis\": {\n    \"name\": \"Chronic Kidney Disease (Stage IV), likely diabetic nephropathy with superimposed hypertensive nephropathy\",\n    \"confidence\": 0.95,\n    \"icd_code\": \"N18.4\"\n  },\n  \"differential_diagnoses\": [\n    {\n      \"name\": \"Diabetic Nephropathy (primary contributor)\",\n      \"confidence\": 0.85,\n      \"icd_code\": \"E11.2\"\n    },\n    {\n      \"name\": \"Hypertensive Nephropathy (secondary contributor)\",\n      \"confidence\": 0.80,\n      \"icd_code\": \"I12.9\"\n    },\n    {\n      \"name\": \"Heart Failure with Renal Dysfunction\",\n      \"confidence\": 0.65,\n      \"icd_code\": \"I50.9\"\n    },\n    {\n      \"name\": \"Amyloidosis (less likely, but cannot be excluded)\",\n      \"confidence\": 0.20,\n      \"icd_code\": \"E85.4\"\n    }\n  ],\n  \"key_findings\": [\n    \"Rising serum creatinine (3.1 mg/dL, eGFR 22 mL/min/1.73 m\u00b2)\",\n    \"3+ proteinuria with UPCR 5.2 g/g\",\n    \"Hypertension (168/92 mmHg)\",\n    \"Hyperkalemia (5.6 mmol/L)\",\n    \"Metabolic acidosis (bicarbonate 17 mmol/L)\",\n    \"Bilateral pitting edema and pruritus\",\n    \"Bibasilar crackles on lung exam\"\n  ],\n  \"tests\": [\n    {\n      \"test\": \"Electrocardiogram (ECG)\",\n      \"priority\": \"urgent\"\n    },\n    {\n      \"test\": \"Echocardiogram\",\n      \"priority\": \"urgent\"\n    },\n    {\n      \"test\": \"Parathyroid hormone (PTH) level\",\n      \"priority\": \"routine\"\n    },\n    {\n      \"test\": \"25-Hydroxyvitamin D level\",\n      \"priority\": \"routine\"\n    },\n    {\n      \"test\": \"Renal biopsy (consider if rapidly progressive or atypical features)\",\n      \"priority\": \"routine\"\n    }\n  ],\n  \"management\": {\n    \"immediate\": [\n      \"Restrict fluid intake if volume overloaded\",\n      \"Dietary protein restriction (0.8-1.0 g/kg/day)\",\n      \"Strict blood pressure control (goal <130/80 mmHg)\"\n    ],\n    \"medications\": [\n      \"Lisinopril: 10 mg PO daily (titrate to achieve BP control, monitor K+)\",\n      \"Metformin: hold or reduce dose if eGFR <30 mL/min/1.73 m\u00b2 (current HbA1c 9.2% suggests poor glycemic control, but caution with renal impairment)\",\n      \"Furosemide: 20-40 mg PO twice daily (adjust based on volume status and electrolytes)\",\n      \"Kayexalate (sodium polystyrene sulfonate): 15-30 g PO daily (for hyperkalemia, monitor K+ closely)\",\n      \"Calcitriol: 0.25 mcg PO daily (if PTH elevated, adjust based on calcium/phosphorus levels)\"\n    ],\n    \"consultations\": [\n      \"Nephrology: urgent (for CKD stage IV management and potential dialysis planning)\",\n      \"Cardiology: routine (for heart failure evaluation)\",\n      \"Diabetology: routine (for glycemic control optimization)\"\n    ]\n  },\n  \"red_flags\": [\n    \"Rapid decline in renal function\",\n    \"Severe hyperkalemia\",\n    \"Worsening volume overload\",\n    \"Acute kidney injury superimposed on CKD\",\n    \"Uremic symptoms (pruritus, anorexia, confusion)\"\n  ]\n}\n```",
  "latency": 39.35498309135437,
  "timestamp": "2025-09-07T17:25:22.596434",
  "cached_at": "2025-09-07T17:25:22.596439",
  "tokens_used": 1414,
  "input_tokens": 571,
  "output_tokens": 843
}